- Home
- Labeler Index
- Regeneron Pharmaceuticals, Inc.
- 61755-019
- NDC Crossover: 61755-019 Inmazeb
NDC Crossover 61755-019 Inmazeb
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Atoltivimab; Maftivimab; Odesivimab
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 61755-019 – Inmazeb, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Inmazeb
- OR Generic name: Atoltivimab, Maftivimab, And Odesivimab-ebgn
- AND the same Administration Route: intravenous
- OR Dosage Form: injection, solution
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 61755-018 | Inmazeb | Atoltivimab, Maftivimab, And Odesivimab-ebgn | Injection, Solution | Intravenous | Regeneron Pharmaceuticals, Inc. | Human Prescription Drug |
